The FDA has just approved Sanofi’s lixisenatide (Adlyxin), a new glucagon-like peptide-1 (GLP-1) receptor agonist to improve glycemic control, in conjunction with diet and exercise, in adults with type 2 diabetes.
The former owner of a pharmacy in Lexington, Kentucky, has been sentenced to more than 6 years in prison for stealing $1.1 million from a charity called Chronic Disease Fund.
Joan Bennett, DNP, FNP-BC, a clinician with RediClinic, discusses the role of the pharmacist in curbing inappropriate antibiotic use.
Debra Michaud, RN, MS, ARNP, FCP-C, MBA, senior clinician with MinuteClinic/CVS Health, outlines some of the major pharmacologic treatment options for psoriasis.
Teva Pharmaceuticals has launched sumatriptan succinate injection, the generic equivalent of GlaxoSmithKline’s Imitrex, in 4 mg and 6 mg dosage strengths.